Poll says Utahns want help on drug pricing
A new survey in Utah finds an overwhelming majority of voters consider drug prices as a top issue in the state, blame drug companies for high prices and want more transparency in drug pricing.
The survey was done by Lower Drug Prices for Utah (LDPUT), conducted by Morning Consult and reported by Utahpolicy.com from a press release. The survey was released just as the Utah Legislature begins its 2020 session.
Get the latest state-specific policy intelligence for the health care sector delivered to your inbox.
LDPUT spokesman Jeff Johnson said the survey shows that residents want state lawmakers to come up with a solution for high drug prices.
“Utahns are deeply concerned with out-of-control prescription drug prices and are demanding action from state lawmakers to hold Big Pharma accountable,” Johnson said. “By decisive margins, Beehive State voters hold Big Pharma responsible for rising drug prices and support greater list price transparency that will shine a light on drug companies’ egregious practices and discourage price hikes.”
The Pharmaceutical Entity Transparency Act is expected to be introduced this legislative session, according to Utahpolicy.com.
The takeaways from the LDPUT survey include:
- 71 percent of Utah voters blame pharmaceutical companies for “the rising price of prescription drugs.’
- 85 percent of Utah voters identify the rising price of prescription drugs as an important issue facing the state.
- 87 percent of Utah voters say Utah lawmakers should “increase transparency for prescription drug list prices,” the price set by the manufacturer. That includes 90 percent Republicans, 83 percent of independents, and 85 percent of Democrats.
- By a 61 percent point margin, Utahns say they support The Pharmaceutical Entity Transparency Act and 75 percent of voters say it is important lawmakers pass the transparency proposal this year.